TUMORI, vol.85, no.6, pp.483-487, 1999 (SCI-Expanded)
Aims and background: A pilot study of neoadjuvant chemotherapy with cyclophosphamide-epirubicin-5-fluorouracil (FEC) was performed on 85 patients with locally advanced breast cancer.